cover
Contact Name
Editor PSR
Contact Email
article@farmasi.ui.ac.id
Phone
+62-21-27608403
Journal Mail Official
psr@farmasi.ui.ac.id
Editorial Address
3rd Floor, A Building, Rumpun Ilmu Kesehatan Kampus Baru UI Depok, 16424, Indonesia
Location
Kota depok,
Jawa barat
INDONESIA
Pharmaceutical Sciences and Research (PSR)
Published by Universitas Indonesia
ISSN : 24072354     EISSN : 24770612     DOI : https://doi.org/10.7454/psr
Core Subject :
Aims Pharmaceutical Sciences and Research (PSR), an international, peer-reviewed, open access, and official journal from Faculty of Pharmacy, Universitas Indonesia, aims to disseminate research results and findings in Pharmaceutical Sciences and Practices. Major area of interest is natural products in drug discovery and development. We also consider other areas related to pharmaceutical sciences and practices. PSR publishes content in English language to promote the sharing of knowledge to international scholars. PSR publish 5 types of articles: 1. Original article 2. Case report 3. Case series 4. Review article 5. Mini review article Scope Researches in Pharmaceutical Sciences and Practices which are covered by PSR are within these subject areas: - Pharmacognosy and Phytochemistry - Pharmaceutical Chemistry - Pharmaceutical Technology - Pharmaceutical Biotechnology - Clinical Pharmacy - Pharmacology-Toxicology - Social and Administrative Pharmacy, including Pharmacoeconomy
Arjuna Subject : -
Articles 365 Documents
Case Report of Mixed Liver Injury Following Five Days Exposure to Cefepime in Young Adults Widyati, Widyati; Harijono, Pandu; Wibowo Rencong, Gunady
Pharmaceutical Sciences and Research Vol. 13, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Drug-induced liver injury (DILI) remains a challenge in clinical practice and is still a diagnosis of exclusion. Although it has a low incidence amongst the general population, DILI accounts for most cases of acute liver failure with a fatality rate of up to 50%. Case : A 56-year-old male was transferred to the Intensive Care Unit (ICU) with fever and severe thrombocytopenia,17,000. The patient was diagnosed with suspected sepsis and potential disseminated intravascular coagulation (DIC). Consequently, the patient was put on cefepime, administered 2g three times daily for over 30 minutes, and combined with amikacin at 1500 mg to be infused over 60 minutes. We adjusted the pharmacokinetics of cefepime on day three by changing the administration time from a 30-minute infusion to a 4-hour infusion. We discontinued amikacin on day five and continued cefepime. On day seven, the patient looked jaundiced at the sclera and skin. Upon drug chart review, we discovered that cefepime was associated with jaundice, according to post-marketing data. We ceased cefepime and ordered a Liver Function Test (LFT). The LFT results showed total bilirubin of 12 mg/dL and alkaline phosphatase nearly 1.5 times the normal level. Using the RUCAM score, the cholestatic injury was classified as mixed type with an R score of 4. Three days after discontinuing cefepime, serum total bilirubin and direct bilirubin levels decreased to 10.2 and 6.8 mg/dL, respectively. By day 25, the total bilirubin and alkaline phosphatase levels returned to near normal.
Isolation, Structural Characterization, and In Vitro Bioactivity Assessment of Extracellular Vesicles Derived from Lacticaseibacillus paracasei Ramadiani, Dwi Liza; Rahmasari, Ratika; Wahyuni, Tri; Kusmiati, Kusmiati; Irawan, Herman; Pasaribu, Khatarina Meldawati
Pharmaceutical Sciences and Research Vol. 13, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The field of study on extracellular vesicles (EVs) has recently focused on probiotic bacteria, due to their ability to exhibit a wide variety of biological activity. Therefore, this study aims to evaluate the effect of nutrient modulation during Lacticaseibacillus paracasei cultivation on EVs production and bioactivity. EVs were isolated by ultrafiltration method and were characterized using NTA and cryo-TEM. An in vitro evaluation was used to assess the bioactivities, antioxidant properties, anti-inflammatory potential, and ability to inhibit α-glucosidase activity. The results showed that the 2 LPEV exhibited the characteristics of vesicles with size of 96.04–100.29 nm. Cultivation in 50% MRS increased the number of particles (5.70 × 10⁹ particles/mL) compared with 100% MRS (4.46 × 10⁹ particles/mL). In addition, LPEV exhibited moderate antioxidant activity (15.5–34.6%), strong anti-inflammatory activity (90.6–99.2%), and substantial α-glucosidase inhibitory activity (75.5–79.7%). The reducing nutrients increased EV production without changing their physical and chemical properties or biological activity. This suggest that changing nutrients is an easy way to increase L. paracasei EV production and use LPEVs in the future for biomedical studies.
Oral Insulin Nanoparticles in Animal Models of Diabetes: A Systematic Review of Recent Studies Rahmania, Dhea; Shiyan, Shaum; Kusnadi, Yulianto; Subandrate, Subandrate; Palungan, Juliana; Rosdah, Ayeshah Augusta
Pharmaceutical Sciences and Research Vol. 13, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Oral insulin has long been explored as a potential alternative to injectable insulin therapy. However, the development remains challenging due to enzymatic degradation in the gastrointestinal tract and limited intestinal absorption. Nanoparticle-based delivery systems have also been proposed as a strategy to protect insulin and improve uptake after oral administration. Therefore, this systematic review aimed to summarize recent preclinical studies investigating oral insulin nanoparticles in diabetic animal models and examine the reported pharmacological outcomes. Relevant studies were identified through database searches in PubMed, SpringerLink, and ScienceDirect using predefined keywords related to oral insulin, nanoparticles, diabetes, and animal models. Articles published between January 2021 and 2026 were screened following the predefined eligibility criteria. After removal of duplicates and records that did not meet accessibility requirements, titles and abstracts were reviewed, followed by full-text evaluation of potentially relevant studies. Non-English articles, studies without accessible full text, and analyses where insulin was not the primary intervention were excluded. A total of 16 studies met the inclusion criteria and were included in the narrative synthesis. The results showed that most investigations focused on polymer-based nanoparticles, but silica-based, biomimetic, and hybrid systems were also reported. Across studies, oral insulin nanoparticles reduced blood glucose levels in diabetic animals. The magnitude, onset, and duration of the glycemic response varied considerably among formulations. Current evidence suggested that oral insulin nanoparticles could produce pronounced glucose-lowering effects with rapid onset and sustained activity, depending on the formulation. Further standardized pharmacological evaluations in animal models were needed to assess translational potential for human application.
Implementation of a Modified Trigger Tool for Adverse Drug Reaction Detection in Pediatric with COVID-19 in Indonesia Maria, Nisa; Khaerani, Avini Risda; Hamdani, Indri Yuliani; Larasati, Annisa Lazuardi; Kusumawardani, Larasati Arrum
Pharmaceutical Sciences and Research Vol. 13, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Pediatric patients are vulnerable to adverse drug reactions (ADRs), necessitating prompt monitoring of treatment-related adverse events (AEs). This study analyzed ADRs in pediatric COVID-19 patients using a modified trigger tool to identify AEs, followed by causality analysis with the Naranjo Algorithm, and evaluated the tool’s performance. A cross-sectional, single-center retrospective study was conducted at a hospital in Indonesia from August 2020 to July 2021, using total sampling of pediatric patients aged one to≥24 hours with COVID-19. AEs were identified using 23 triggers (15 laboratory result, eight drug-administration). A total of 242 positive triggers were detected among 120 patients (mean two triggers/patient, range one to four), corresponding to 527 suspected drug–event associations assessed for causality. The Naranjo Algorithm classified 357 (67.7%) associations as possible, 32 (6.1%) as probable, and 138 (26.2%) as doubtful. Accordingly, 389 ADR events were identified from the possible and probable categories. The most common ADRs from drug-administration triggers were peptic ulcers (84.2%), hypersensitivity (29.2%), and nausea (27.5%); from laboratory result triggers, increased aspartate aminotransferase (5.8%) and alanine transaminase (1.7%) were most frequent. These ADRs were most frequently associated with ceftriaxone (48.6%) and azithromycin (26.0%). Of the 12 trigger types detected, 11 identified at least one ADR, with PPVs ranging from 44.4% to 100%. The modified trigger tool showed potential utility in detecting ADRs in pediatric patients; prospective studies in routine practice are needed to strengthen pharmacovigilance.
Phytochemical Screening and Assessment of Antibacterial and Antioxidant Activities of the Crude Extracts from the Leaves of Vernonia lasiopus Against Diarrhea-Associated Bacteria Iradukunda, Jackson; Muhizi, Théoneste
Pharmaceutical Sciences and Research Vol. 13, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Vernonia lasiopus O. Hoffm., a member of the family Asteraceae, has been traditionally used in the management of diarrhea and has also been reported to possess antioxidant properties. However, its biological activities and therapeutic potential have not been adequately established through scientific investigation. This study aimed to evaluate the antibacterial activity of crude leaf extracts of V. lasiopus against Escherichia coli and Staphylococcus aureus and to assess their antioxidant activity using the 2,2 diphenyl 1 picrylhydrazyl (DPPH) assay. The powdered leaves were extracted by maceration using methanol, diethyl ether, cyclohexane, and acetone. Phytochemical screening was performed to determine the classes of secondary metabolites present in the extracts. The screening detected flavonoids, phenols, saponins, steroids, tannins, quinones, terpenoids, alkaloids, coumarins, and glucosides across the extracts. The methanol extract exhibited the strongest DPPH radical-scavenging activity, with an IC₅₀ value of 0.126 mg/mL, compared with 2.605 mg/mL for ascorbic acid. In the antibacterial assay, the methanol extract produced inhibition zones of 17.23 ± 1.32 mm against S. aureus and 16.19 ± 1.03 mm against E. coli. The acetone and diethyl ether extracts showed moderate activity, whereas no inhibition zones were observed in the negative controls. The observed activities may be associated with the phytochemical classes detected in the extracts, although further studies are needed to establish the contributions of individual compounds. These findings provide preliminary evidence of the in vitro antibacterial and antioxidant potential of V. lasiopus leaf extracts and support further investigations into their active constituents, toxicity profiles, and biological activities.